Okinawa Institute of Science and Technology

Searches through March 18, 2026, confirm additional PubPeer-prompted retractions in lung cancer-related papers, including a notice for Long noncoding RNA FAM201A mediating metastasis and a Sage journal retraction for in vitro assays in human lung cancer cells, but these appear as figure concerns rather than confirmed fraud. No developments on ongoing high-profile cases such as OIST's response to Paola Laurino's flagged papers, Sonia Melo's MD Anderson lawsuit, or Taylor & Francis investigation of the Rose/McKernan/Speicher Autoimmunity Reviews paper. PubPeer flags on 2026 Nature Medicine lung cancer trial and Cancer Discovery papers persist without resolutions, while Retraction Watch reports remain focused on non-biomedical issues.